Abstract
Nephrology in the United States of America (USA) has grown into a major medical specialty over the past 60 years. Although the specialty includes the management of patients with acute kidney injury, the deciphering of complex acid-base disorders, and the identification and management of patients with glomerular diseases, for many of the 10,883 US nephrologists, it centers around the diagnosis and treatment of patients who have various stages of kidney disease. In the USA, there were approximately 726,000 patients on dialysis or living with a kidney transplant. The management of dialysis patients is tightly regulated by the Centers for Medicare and Medicaid Services, which also is a principal payer for the majority of dialysis and transplantation services in the USA. This chapter will examine the beginnings of the field and the history of how nephrology in the USA evolved. It will discuss how US physicians are approaching modalities of care as well as specific issues such as dialysis adequacy, arteriovenous access barriers, hospitalization rates, volume and cardiovascular disease, mineral and bone disorders, potassium management, and kidney transplantation. It will discuss various opportunities for young physicians and conclude with what lies in the future for nephrologists and more importantly for patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brookings Institute. 15 December 2019. Available from: https://www.brookings.edu/.
Changes in U.S. family finances from 2013 to 2016: evidence from the survey of consumer finances: The Federal Reserve System. Available from: https://www.federalreserve.gov/publications/files/scf17.pdf.
National Center for Health Statistics. 15 December 2019. Available from: https://www.cdc.gov/nchs/fastats/access-to-health-care.htm.
Fadem SZ. Issues in dialysis. 1st ed. New York: Nova Science Publishers; 2012. 361 p.
Cameron JS. The prehistory of haemodialysis as a treatment for uraemia. G Ital Nefrol. 2016;33(Suppl 66):33.S66.2.
Murphy WP Jr, Swan RC Jr, Walter CW, Weller JM, Merrill JP. Use of an artificial kidney. III. Current procedures in clinical hemodialysis. J Lab Clin Med. 1952;40(3):436–44.
Blagg CR. Belding Hibbard Scribner—better known as Scrib. Clin J Am Soc Nephrol. 2010;5(12):2146.
Blagg CR. The 50th anniversary of long-term hemodialysis: University of Washington Hospital, March 9th, 1960. J Nephrol. 2011;24(Suppl 17):S84–8.
Chronic Kidney Disease (CKD) Surveillance System – Centers for Disease Control and Prevention (CDC). 12 December 2019. Available from: https://nccd.cdc.gov/ckd/Default.aspx.
Fresenius Medical Care AG & Co. KGaA (FMS). Available from: https://finance.yahoo.com/quote/FMS/.
Shinkman R. The big business of dialysis care. NEJM Catalyst. 2016 https://catalyst.nejm.org/doi/full/10.1056/CAT.16.0826.
DaVita Inc. (DVA). Available from: https://finance.yahoo.com/quote/DVA/.
DaVita Inc 2018 Form 10-K Annual Report. 2018.
Chronic Kidney Disease in the United States – 2019. Atlanta: Centers for Disease Control and Prevention; 2019. Available from: https://www.cdc.gov/kidneydisease/pdf/2019_National-Chronic-Kidney-Disease-Fact-Sheet.pdf.
U.S. Renal Data System. USRDS 2018 annual data report volume 2: end-stage renal disease in the United States. Bethesda: National Institute of Health; 2018.
Denny GB, Golper TA. Does hemodialyzer reuse have a place in current ESRD care: “to be or not to be?”. Semin Dial. 2014;27(3):256–8.
Fadem SZ. Milestones in dialysis in issues in dialysis. New York: Nova Science Publishers; 2012.
Prowant BF, Schmidt LM, Twardowski ZJ, Griebel CK, Burrows LK, Ryan LP, et al. Peritoneal dialysis catheter exit site care. ANNA J. 1988;15(4):219–23.
Ackad A, Simonian GT, Steel K, Parisi C, Mancini S, Douglas C, et al. A journey in reversing practice patterns: a multidisciplinary experience in implementing DOQI guidelines for vascular access. Nephrol Dial Transplant. 2005;20(7):1450–5.
DOPPS practice monitor: reporting contemporary trends in US dialysis practice. Ann Arbor: Arbor Research Collaborative for Health; 2019 [updated 2019, May]. Available from: https://www.dopps.org/dpm/.
Friedman AN, Fadem SZ. Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol. 2010;21(2):223–30.
Suzuki M, Satoh N, Nakamura M, Horita S, Seki G, Moriya K. Bacteremia in hemodialysis patients. World J Nephrol. 2016;5(6):489–96.
Brunelli SM, Van Wyck DB, Njord L, Ziebol RJ, Lynch LE, Killion DP. Cluster-randomized trial of devices to prevent catheter-related bloodstream infection. J Am Soc Nephrol. 2018;29(4):1336–43.
Parker TF 3rd, Glassock RJ, Steinman TI. Conclusions, consensus, and directions for the future. Clin J Am Soc Nephrol. 2009;4(Suppl 1):S139–44.
Flythe JE, Kshirsagar AV, Falk RJ, Brunelli SM. Associations of posthemodialysis weights above and below target weight with all-cause and cardiovascular mortality. Clin J Am Soc Nephrol. 2015;10(5):808–16.
Flythe JE, Brunelli SM. The risks of high ultrafiltration rate in chronic hemodialysis: implications for patient care. Semin Dial. 2011;24(3):259–65.
Flythe JE, Kimmel SE, Brunelli SM. Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int. 2011;79(2):250–7.
Christakos S, Dhawan P, Porta A, Mady LJ, Seth T. Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol. 2011;347(1–2):25–9.
Chistiakov DA, Sobenin IA, Orekhov AN, Bobryshev YV. Mechanisms of medial arterial calcification in diabetes. Curr Pharm Des. 2014;20(37):5870–83.
Kovesdy CP, Rowan CG, Conrad A, Spiegel DM, Fogli J, Oestreicher N, et al. Real-world evaluation of patiromer for the treatment of hyperkalemia in hemodialysis patients. Kidney Int Rep. 2019;4(2):301–9.
Fishbane S, Ford M, Fukagawa M, McCafferty K, Rastogi A, Spinowitz B, et al. A phase 3b, randomized, double-blind, placebo-controlled study of sodium zirconium cyclosilicate for reducing the incidence of predialysis hyperkalemia. J Am Soc Nephrol. 2019;30:1723–33.
National Data – Organ Procurement and Transplantation Network. Richmond: UNOS; 2019.
Patzer RE, Smith K, Basu M, Gander J, Mohan S, Escoffery C, et al. The ASCENT (allocation system changes for equity in kidney transplantation) study: a randomized effectiveness-implementation study to improve kidney transplant waitlisting and reduce racial disparity. Kidney Int Rep. 2017;2(3):433–41.
Purnell TS, Luo X, Kucirka LM, Cooper LA, Crews DC, Massie AB, et al. Reduced racial disparity in kidney transplant outcomes in the United States from 1990 to 2012. J Am Soc Nephrol. 2016;27(8):2511–8.
Nicolaou N, Renkema KY, Bongers EMHF, Giles RH, Knoers NVAM. Genetic, environmental, and epigenetic factors involved in CAKUT. Nat Rev Nephrol. 2015;11(12):720–31.
Weaver DJ Jr, Somers MJG, Martz K, Mitsnefes MM. Clinical outcomes and survival in pediatric patients initiating chronic dialysis: a report of the NAPRTCS registry. Pediatr Nephrol. 2017;32(12):2319–30.
Wetmore JB, Guo H, Liu J, Collins AJ, Gilbertson DT. The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis. Kidney Int. 2016;90(4):853–60.
Ziemba JB, Matlaga BR. Epidemiology and economics of nephrolithiasis. Investig Clin Urol. 2017;58(5):299–306.
Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE. Polycystic kidney disease. Nat Rev Dis Primers. 2018;4(1):50.
Kashtan CE, Ding J, Gregory M, Gross O, Heidet L, Knebelmann B, et al. Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport syndrome research collaborative. Pediatr Nephrol. 2013;28(1):5–11.
Caberto S, Fadem S. In: Fadem S, editor. Genetic renal tubular disorders in essentials of chronic kidney disease. New York: Nova Science Publishers; 2015.
Rastogi A, Arman F, Asaturyan A, Ameen K, Singhal R. Other causes of chronic kidney disease. In: Fadem S, editor. Essentials of chronic kidney disease. New York: Nova Science Publishers; 2015.
Quigley L. E S. report on a survey of nephrologists in early years of practice. Washington, DC: George Washington Health Workforce Institute; 2018.
Salaries.com. Available from: https://www.salary.com/research/salary/benchmark/staff-nurse-rn-renal-dialysis-salary/.
Gura V, Rivara MB, Bieber S, Munshi R, Smith NC, Linke L, et al. A wearable artificial kidney for patients with end-stage renal disease. JCI Insight. 2016;1(8):e86397.
Nichols JE, La Francesca S, Vega SP, Niles JA, Argueta LB, Riddle M, et al. Giving new life to old lungs: methods to produce and assess whole human paediatric bioengineered lungs. J Tissue Eng Regen Med. 2017;11(7):2136–52.
Goto T, Hara H, Sanbo M, Masaki H, Sato H, Yamaguchi T, et al. Generation of pluripotent stem cell-derived mouse kidneys in Sall1-targeted anephric rats. Nat Commun. 2019;10(1):451.
Roelen BAJ. Regenerative medicine: taming the chimaera. Stem Cell Rep. 2018;11(4):849–51.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Anumudu, S.J., Fadem, S.Z. (2021). Nephrology in the United States of America. In: Moura-Neto, J.A., Divino-Filho, J.C., Ronco, C. (eds) Nephrology Worldwide. Springer, Cham. https://doi.org/10.1007/978-3-030-56890-0_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-56890-0_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-56889-4
Online ISBN: 978-3-030-56890-0
eBook Packages: MedicineMedicine (R0)